Published January 28, 2022 | Version 0
Journal article Open


  • 1. Instituto de Hematología e Inmunología, La Habana, Cuba.


Introduction: Chronic myeloid leukemia is a chronic myeloproliferative neoplasm characterized by the uncontrolled proliferation of myeloid precursors and autoimmune hemolytic anemia is an unregulated immune reaction towards the antigens themselves that are on the surface of the membrane of red blood cells. The combination of these diseases is extremely rare and even greater when chronic myeloid leukemia is in an erythroid blast crisis.

Objective: To describe a case with the coexistence of chronic myeloid leukemia in erythroid blast crisis and autoimmune hemolytic anemia.

Clinical case: Patient with a history of chronic myeloid leukemia who presents an erythroid blast crisis and develops autoimmune hemolytic anemia due to warm IgG antibodies. The treatment for both diseases will be administered. After a clinical improvement of the autoimmune hemolytic anemia, he maintained the erythroid blast crisis and was administered an intensive chemotherapy regimen where complications occurred and he died.


The treatment with steroids in autoimmune hemolytic anemia in patients with chronic myeloid leukemia is effective when they are in the chronic phase of the disease, but is little responsive when they are in blast crisis, as was the case we present, and the fatal outcome in the patient was multifactorial.


NF V05I01.2.pdf

Files (740.7 kB)

Name Size Download all
740.7 kB Preview Download

Additional details

Related works

Is referenced by
Journal article: 10.33826/ijmras/v05i01.2 (DOI)


  • 1. Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring. Am J Hematol. 2018; 91(2): 252–65.
  • 2. Kang ZJ, Liu YF, Xu LZ, Long ZJ, Huang D, Yang Y et al. The Philadelphia chromosome in leukemogenesis. Chin J Cancer 2016; 35(48):1-15.
  • 3. Nagales-Nagamos R, Gentile T, Vajpayee N. Erythroid blast crisis in chronic myelogenous leukemia: Case report and review of literature. Leukemia Res Rep.2016; 5:18-22.
  • 4. Domínguez Domínguez G, Marsán Suárez V, Hernández Padrón C, Lam Díaz RM, Quintero Sierra Y, Olivera Morán O. Caracterización inmunofenotípica de pacientes con leucemia mieloide crónica en crisis blástica. Rev Cubana Hematol Inmunol Hemoter.2017;33(4). Disponible en:
  • 5. Kalfa TA. Warm antibody autoimmune hemolytic anemia. Hematol Am SocHematolEduc Program. 2016; 2016(1):690–7.
  • 6. Go RS, Winters JL, Kay NE. How I treat autoinmune hemolytic anemia. Blood. 2017; 129(22):2971–9.
  • 7. Tamura H, Ogata K, Yokose N, et al.Autoimmunehemolytic anemia in patientswith de novoacutemyelocyticleukemia. Ann Hematol 1996;72:45-47. DOI: 10.1007/BF00663016. [PubMed]
  • 8. Jacob J.S, Suman F.R, Scott J.X, Latha MS Co existence of acute promyelocytic leukemia and autoimmune haemolyticanaemia in a girl – A diagnostic and therapeutic challenge. Int J Pediatr Res.2016;3(8):640-643.doi:10.17511/ijpr.2016.8.15.
  • 9. Ben-Ishay D, Freund M, Groen JJ. A case of autoimmune hemolytic anemia with circulating cold agglutinins presenting for many years as" hypersplenism" and terminating in leukemia. Blood. 1963 Jul 1;22(1):100-8.
  • 10. Arbaje YM, Beltran G. Chronic myelogenous leukemia complicated by autoimmune hemolytic anemia. The American journal of medicine. 1990 Feb 28; 88(2):197-9. [PubMed].